Literature DB >> 19580406

Engineering tissue alternatives to animals: applying tissue engineering to basic research and safety testing.

Anthony Holmes1, Robert Brown, Kevin Shakesheff.   

Abstract

The focus for the rapid progress in the field of tissue engineering has been the clinical potential of the technology to repair, replace, maintain or enhance the function of a particular tissue or organ. However, tissue engineering has much wider applicability in basic research and safety testing, which is often not recognized owing to the clinical focus of tissue engineers. Using examples from a recent National Centre for the Replacement, Refinement and Reduction of Animals in Research/Biotechnology and Biological Sciences Research Council symposium, which brought together tissue engineers and scientists from other research communities, this review highlights the potential of tissue engineering to provide scientifically robust alternatives to animals to address basic research questions and improve drug and chemical development in the pharmaceutical and chemical industries.

Mesh:

Year:  2009        PMID: 19580406     DOI: 10.2217/rme.09.26

Source DB:  PubMed          Journal:  Regen Med        ISSN: 1746-0751            Impact factor:   3.806


  3 in total

1.  Pioneering better science through the 3Rs: an introduction to the national centre for the replacement, refinement, and reduction of animals in research (NC3Rs).

Authors:  Natalie Burden; Kathryn Chapman; Fiona Sewell; Vicky Robinson
Journal:  J Am Assoc Lab Anim Sci       Date:  2015-03       Impact factor: 1.232

2.  Anti-Cancer Activity Profiling of Chemotherapeutic Agents in 3D Co-Cultures of Pancreatic Tumor Spheroids with Cancer-Associated Fibroblasts and Macrophages.

Authors:  So-Dam Jang; Jeeyeun Song; Hyun-Ah Kim; Chang-Nim Im; Iftikhar Ali Khawar; Jong Kook Park; Hyo-Jeong Kuh
Journal:  Cancers (Basel)       Date:  2021-11-26       Impact factor: 6.639

3.  Osteoblast-osteoclast co-cultures: A systematic review and map of available literature.

Authors:  Stefan J A Remmers; Bregje W M de Wildt; Michelle A M Vis; Eva S R Spaander; Rob B M de Vries; Keita Ito; Sandra Hofmann
Journal:  PLoS One       Date:  2021-11-04       Impact factor: 3.240

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.